U-Blot® Research Grade SeribantumabCat. No. WA3520Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SeribantumabCat. No. WA3520
U-Blot® Research Grade SerclutamabCat. No. WA3519
U-Blot® Research Grade SeniprutugCat. No. WA3518
U-Blot® Research Grade SemzuvolimabCat. No. WA3517
U-Blot® Research Grade SemorinemabCat. No. WA3516
U-Blot® Research Grade SelicrelumabCat. No. WA3515
U-Blot® Research Grade selcodebartCat. No. WA3514
U-Blot® Research Grade SecukinumabCat. No. WA3513
U-Blot® Research Grade SatumomabCat. No. WA3512
U-Blot® Research Grade SatralizumabCat. No. WA3511
U-Blot® Research Grade SasanlimabCat. No. WA3510
U-Blot® Research Grade SarilumabCat. No. WA3509